Literature DB >> 23721875

Multisystem dysregulation in painful temporomandibular disorders.

Hong Chen1, Andrea Nackley, Vanessa Miller, Luda Diatchenko, William Maixner.   

Abstract

UNLABELLED: Multiple physiological and psychological regulatory domains may contribute to the pathophysiology of pain in temporomandibular disorder (TMD) and other bodily pain conditions. The purpose of this study was to evaluate the relationship between multisystem dysregulation and the presence of TMD pain, as well as the presence of different numbers of comorbid pain conditions in TMD. Secondary data analysis was conducted in 131 non-TMD (without comorbid pain) controls, 14 TMD subjects without comorbid pain, 78 TMD subjects with 1 comorbid pain, and 67 TMD subjects with multiple comorbid pain conditions who participated in a TMD genetic study. Twenty markers from sensory, autonomic, inflammatory, and psychological domains were evaluated. The results revealed that 1) overall dysregulation in multiple system domains (OR [odds ratio] = 1.6, 95% confidence interval [CI] = 1.4-1.8), particularly in the sensory (OR = 1.9, 95% CI = 1.3-2.9) and the psychological (OR = 2.1, 95% CI = 2.1-2.7) domains, were associated with increased likelihood of being a painful TMD case; and 2) dysregulations in individual system domains were selectively associated with the increased odds of being a TMD case with different levels of comorbid persistent pain conditions. These outcomes indicate that heterogeneous multisystem dysregulations may exist in painful TMD subgroups, and multidimensional physiological and psychological assessments can provide important information regarding pathophysiology, diagnosis, and management of pain in TMD patients. PERSPECTIVE: The concurrent assessment of multiple physiological and psychological systems is critical to our understanding of the pathophysiological processes that contribute to painful TMD and associated comorbid conditions, which will ultimately guide and inform appropriate treatment strategies that address the multisystem dysregulation associated with complex and common persistent pain conditions.
Copyright © 2013 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Temporomandibular disorders; comorbid pain conditions; headache; multisystem dysregulation

Mesh:

Year:  2013        PMID: 23721875      PMCID: PMC3770463          DOI: 10.1016/j.jpain.2013.03.011

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  84 in total

1.  Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association.

Authors:  G F Fletcher; G J Balady; E A Amsterdam; B Chaitman; R Eckel; J Fleg; V F Froelicher; A S Leon; I L Piña; R Rodney; D A Simons-Morton; M A Williams; T Bazzarre
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

2.  Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study.

Authors:  D J Wallace; M Linker-Israeli; D Hallegua; S Silverman; D Silver; M H Weisman
Journal:  Rheumatology (Oxford)       Date:  2001-07       Impact factor: 7.580

3.  The relationship between resting blood pressure and acute pain sensitivity in healthy normotensives and chronic back pain sufferers: the effects of opioid blockade.

Authors:  Stephen Bruehl; Ok Yung Chung; Pamela Ward; Benjamin Johnson; James A McCubbin
Journal:  Pain       Date:  2002-11       Impact factor: 6.961

4.  Cytokines and depression in cases with fibromyalgia.

Authors:  Ali Gür; Mehmet Karakoç; Kemal Nas; Aziz Denli; Jale Saraç
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

5.  Group differences in pain modulation: pain-free women compared to pain-free men and to women with TMD.

Authors:  Edith E Bragdon; Kathleen C Light; Nancy L Costello; Asgeir Sigurdsson; Shelley Bunting; Kanokporn Bhalang; William Maixner
Journal:  Pain       Date:  2002-04       Impact factor: 6.961

6.  IL-1 beta, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders.

Authors:  Kazuhiro Tominaga; Manabu Habu; Miho Sukedai; Yuriko Hirota; Tetsu Takahashi; Jinichi Fukuda
Journal:  Arch Oral Biol       Date:  2004-06       Impact factor: 2.633

7.  Longitudinal outcome of temporomandibular disorders: a 5-year epidemiologic study of muscle disorders defined by research diagnostic criteria for temporomandibular disorders.

Authors:  Peter Rammelsberg; Linda LeResche; Samuel Dworkin; Lloyd Mancl
Journal:  J Orofac Pain       Date:  2003

Review 8.  A new view of pain as a homeostatic emotion.

Authors:  A D Craig
Journal:  Trends Neurosci       Date:  2003-06       Impact factor: 13.837

9.  Regional cerebral blood flow and cytokines in young females with fibromyalgia.

Authors:  A Gur; M Karakoc; S Erdogan; K Nas; R Cevik; A J Sarac
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

10.  Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation.

Authors:  Frank Petzke; Daniel J Clauw; Kirsten Ambrose; Albert Khine; Richard H Gracely
Journal:  Pain       Date:  2003-10       Impact factor: 6.961

View more
  14 in total

Review 1.  Can quantitative sensory testing move us closer to mechanism-based pain management?

Authors:  Yenisel Cruz-Almeida; Roger B Fillingim
Journal:  Pain Med       Date:  2013-09-06       Impact factor: 3.750

2.  Longitudinal Multilevel Modeling of Facial Pain, Muscle Tension, and Stress.

Authors:  A G Glaros; J M Marszalek; K B Williams
Journal:  J Dent Res       Date:  2016-01-12       Impact factor: 6.116

3.  Self-regulatory ability, fatigue, and the experience of pain: Mechanistic insights from pain-free undergraduates.

Authors:  Ian A Boggero; Suzanne C Segerstrom
Journal:  Psychophysiology       Date:  2019-05-03       Impact factor: 4.016

4.  A novel rat model of temporomandibular disorder with improved face and construct validities.

Authors:  Anthony Phero; Luiz F Ferrari; Norman E Taylor
Journal:  Life Sci       Date:  2021-10-07       Impact factor: 5.037

5.  Epistasis between polymorphisms in COMT, ESR1, and GCH1 influences COMT enzyme activity and pain.

Authors:  Shad B Smith; Ilkka Reenilä; Pekka T Männistö; Gary D Slade; William Maixner; Luda Diatchenko; Andrea G Nackley
Journal:  Pain       Date:  2014-09-16       Impact factor: 6.961

6.  Identification of clusters of individuals relevant to temporomandibular disorders and other chronic pain conditions: the OPPERA study.

Authors:  Eric Bair; Sheila Gaynor; Gary D Slade; Richard Ohrbach; Roger B Fillingim; Joel D Greenspan; Ronald Dubner; Shad B Smith; Luda Diatchenko; William Maixner
Journal:  Pain       Date:  2016-06       Impact factor: 7.926

7.  Dysregulation of the descending pain system in temporomandibular disorders revealed by low-frequency sensory transcutaneous electrical nerve stimulation: a pupillometric study.

Authors:  Annalisa Monaco; Ruggero Cattaneo; Luca Mesin; Eleonora Ortu; Mario Giannoni; Davide Pietropaoli
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

8.  Masticatory sensory-motor changes after an experimental chewing test influenced by pain catastrophizing and neck-pain-related disability in patients with headache attributed to temporomandibular disorders.

Authors:  Roy La Touche; Alba Paris-Alemany; Alfonso Gil-Martínez; Joaquín Pardo-Montero; Santiago Angulo-Díaz-Parreño; Josué Fernández-Carnero
Journal:  J Headache Pain       Date:  2015-03-05       Impact factor: 7.277

Review 9.  Temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper.

Authors:  Arão Nogueira de Araújo; Marion Alves do Nascimento; Eduardo Pondé de Sena; Abrahão Fontes Baptista
Journal:  Drug Healthc Patient Saf       Date:  2014-03-10

10.  Pain profiling of patients with temporomandibular joint arthralgia and osteoarthritis diagnosed with different imaging techniques.

Authors:  Simple Futarmal Kothari; Lene Baad-Hansen; Lars Bolvig Hansen; Niels Bang; Leif Hovgaard Sørensen; Helle Wulf Eskildsen; Peter Svensson
Journal:  J Headache Pain       Date:  2016-06-27       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.